Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Experimental efficacy of the face shield and the mask against emitted and potentially received particles

View ORCID ProfileMichaël Rochoy, Thibaut Fabacher, Isabelle Cosperec, Jean-Michel Wendling
doi: https://doi.org/10.1101/2020.11.23.20237149
Michaël Rochoy
1Univ. Lille, CHU Lille, ULR 2694 - METRICS, CERIM, Liberal practice F-62230 Outreau, F-59000 Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michaël Rochoy
  • For correspondence: michael.rochoy@gmail.com
Thibaut Fabacher
2CHU de Strasbourg, F-67000 Strasbourg, Department of Public Health, GMRC, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Cosperec
3Pharmacist, F-94210 St Maur-des-Fossés, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Michel Wendling
4ACST, F-67000 Strasbourg, France, Occupational Health and Safety Department, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The aim of this study was to evaluate the comparative performance of masks and face shields in different experimental configurations. An experimental setup with two mannequin heads positioned at 1.70m high and at 25 cm each other was used. A fogger generated a particle’s airflow with a speed of 5m/sec from the emitter to the receiver head mannequin. Our aerosol generator produced 3 000 times more particles than a physiological cough situation. A particle counter allowed us to evaluate the number of particles received on a mannequin head located at a very short distance of 25 cm. The amount of all particles up to the selected particle sizes were counted with an optical particle counter on channels 0.3 µm, 0.5 µm, 1 µm, 2.5 µm, 5 µm and 10 µm. The reduction factors with a protection worn by the receiver alone, by the emitter alone and then the double protection of emitter and receiver were calculated. When the receiver alone wore a face shield, the amount of total particles was reduced (54.8%), while the reduction was less when the receiver alone wore a mask (21.8%) (p = 0.003). Wearing a protection by the emitter alone reduced much more the level of particles received by 96.8% for both mask and face shield. The double protection allowed for even better results, but close to the protection of the emitter alone: 98% reduction for the face shields and 97.3% for the masks (p=0.022). Even with small particle size emission (≤0.3µm), results were of the same order. Considering our results, protection of the emitter alone or double protection is much more effective than protection of the receiver only. Validated face shield should be included as part of strategies to safely and significantly reduce transmission in the community setting, in addition to masks or for people with disabilities or medical intolerance to masks.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Exemption

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available in manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 24, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Experimental efficacy of the face shield and the mask against emitted and potentially received particles
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Experimental efficacy of the face shield and the mask against emitted and potentially received particles
Michaël Rochoy, Thibaut Fabacher, Isabelle Cosperec, Jean-Michel Wendling
medRxiv 2020.11.23.20237149; doi: https://doi.org/10.1101/2020.11.23.20237149
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Experimental efficacy of the face shield and the mask against emitted and potentially received particles
Michaël Rochoy, Thibaut Fabacher, Isabelle Cosperec, Jean-Michel Wendling
medRxiv 2020.11.23.20237149; doi: https://doi.org/10.1101/2020.11.23.20237149

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (435)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9018)
  • Forensic Medicine (4)
  • Gastroenterology (422)
  • Genetic and Genomic Medicine (1964)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1333)
  • Health Policy (662)
  • Health Systems and Quality Improvement (522)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10832)
  • Intensive Care and Critical Care Medicine (576)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (223)
  • Neurology (1842)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (358)
  • Occupational and Environmental Health (470)
  • Oncology (1006)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (184)
  • Pain Medicine (126)
  • Palliative Medicine (45)
  • Pathology (267)
  • Pediatrics (583)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4137)
  • Radiology and Imaging (678)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (110)
  • Urology (82)